Pushing Boundaries

Applying physics, chemistry, and cell biology, Satyajit Mayor seeks to understand how cell membranes work.

Written byAnna Azvolinsky
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Satyajit Mayor
Director and Professor,
National Centre for Biological Science Director, Institute for Stem Cell Biology
and Regenerative Medicine (inStem),
Bangalore, India
As a master’s student in Bombay, India, in 1984, Satyajit Mayor worked in an organic chemistry lab devising probes to study synthetic biomembranes. He wanted to apply to molecular biology PhD programs in the U.S., but knew little about American universities except for the names of some of the top engineering and computer science schools where his friends had applied. Mayor, now professor and director of the National Centre for Biological Science (NCBS) in Bangalore, India, happened to be reading Arrowsmith, Sinclair Lewis’s novel partly set at a medical research institute in New York City supposedly modeled in part on the Rockefeller Institute for Medical Research. “I looked up the school in the library and found that this was the place where Fritz Lipmann discovered coenzyme A and where many other famous scientists did important work,” says Mayor.

He wrote to the university’s graduate admissions office and, to his surprise, received a letter from the dean’s office asking him to interview with two Rockefeller researchers who were visiting New Delhi. “It was beyond my means to buy an airline ticket, so I replied that I could meet the researchers if I was sent the airfare, thinking that would be the end of our communication.” To his amazement, Mayor received an airline ticket to travel from Bombay to Dehli to meet Zanvil Cohn at the All India Institute of Medical Sciences. “Cohn was extremely warm and kind and described New York City as a wonderful place, completely selling Rockefeller as a fantasy land for doing science,” says Mayor. “He said that I should plan ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

December 2016

Traffic Cops

The structure and function of nuclear pores

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies